Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

The anticipation surrounding dose optimization data for Pfizer (NYSE:PFE)'s obesity treatment, danuglipron, was also mentioned as a point of interest for the first quarter. However, the analyst ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

Company has Walker Chandiok & Co. LLP as its auditors. As on 31-12-2024, the company has a total of 4.57 Crore shares outstanding.Pfizer Share Price Today is Rs. 4407.30. On previous day, the Pfizer ...

Blockbuster Keytruda makes up nearly half of Merck’s sales. That’s becoming an issue.

Boston Scientific stock jumped Wednesday after the medtech giant easily beat Wall Street's fourth-quarter expectations and ...

Investors rooting for increased M&A and a flurry of IPOs will have to be patient as Q1 tracks with continued low counts on both fronts.

Singapore dollar was steady against its U.S. counterpart in the Asian session amid caution over the latest tariffs from the U ...

A woman holds an anti-Elon Musk sign and an American flag in protest in front of the headquarters for United States Agency ...